Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Return on Invested Capital (2016 - 2024)

Arcadia Biosciences (RKDA) has disclosed Return on Invested Capital for 10 consecutive years, with 0.45% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Return on Invested Capital changed 0.0% year-over-year to 0.45%, compared with a TTM value of 0.45% through Dec 2024, changed 0.0%, and an annual FY2024 reading of 0.39%, down 2.0% over the prior year.
  • Return on Invested Capital was 0.45% for Q4 2024 at Arcadia Biosciences, down from 0.04% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.04% in Q2 2024 and bottomed at 2.03% in Q3 2020.
  • Average Return on Invested Capital over 5 years is 0.83%, with a median of 0.64% recorded in 2020.
  • The sharpest move saw Return on Invested Capital plummeted -250bps in 2020, then skyrocketed 177bps in 2021.
  • Year by year, Return on Invested Capital stood at 0.69% in 2020, then surged by 62bps to 0.26% in 2021, then plummeted by -123bps to 0.58% in 2022, then increased by 24bps to 0.45% in 2023, then fell by 0bps to 0.45% in 2024.
  • Business Quant data shows Return on Invested Capital for RKDA at 0.45% in Q4 2024, 0.04% in Q2 2024, and 0.45% in Q4 2023.